Concepedia

Mahboubeh Yazdanifar

MY

Statistics

Publications

13

Citations

563

H-Index

13

Active since

2013

Affiliations

University of North Carolina at Charlotte(Current)

King's College London

Guy's Hospital

Stanford University

California Institute for Regenerative Medicine

Mahboubeh Yazdanifar is an author at University of North Carolina at Charlotte specializing in oncology, immunology, and immunotherapy.

ORCID

Publications per year

2013–2024

13

Publications

13

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy et al. · Frontiers in Immunology · 2019 · 189 citations · Full text

, , +17

A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis

Ru Zhou, Joseph Curry, Lopamudra Das Roy et al. · Oncogene · 2016 · 64 citations · Full text

, , +14

Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma

Mahboubeh Yazdanifar, Ru Zhou, Priyanka Grover et al. · Cells · 2019 · 62 citations · Full text

, , +17

Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells

Mandana Mohyeddin Bonab, Maryam Mohajeri, Mohammad Ali Sahraian et al. · Archives of Medical Research · 2013 · 45 citations

, , +14

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

Shu-ta Wu, Anthony J. Fowler, Corey B. Garmon et al. · BMC Cancer · 2018 · 43 citations · Full text

, , +17

1–5 of 13